Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuwei Chen

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Cellular Oncology (Dordrecht, Netherlands)|January 20, 2021
Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κBWanyue Wang, Xin Li, Ye Xu, et al.
Journal of Surgical Oncology|August 5, 2011
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancerMingzhu Yin, Haiyu Zhang, Huiyan Li, et al.
Disease Markers|December 8, 2022
<i>ATAD2</i> Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune InfiltrationCan Wang, Yue Yin, Zhenxing Sun, et al.
Molecular Medicine (Cambridge, Mass.)|June 6, 2022
UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosisMengjun Zhang, Yuan Liu, Yue Yin, et al.
Frontiers in Genetics|June 6, 2022
A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian CancerMengjun Zhang, Yunduo Liu, Yuan Liu, et al.
Frontiers in Genetics|September 12, 2022
Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancerMengjun Zhang, Yunduo Liu, Yuan Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic studyYu Zhang, Le Wang, Yunduo Liu, et al.
Discover Oncology|June 25, 2024
miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transitionYing Ma, Yiru Wang, Can Wang, et al.
ACS Nano|April 2, 2019
Quercetin-Modified Metal-Organic Frameworks for Dual Sensitization of Radiotherapy in Tumor Tissues by Inhibiting the Carbonic Anhydrase IXTengchuang Ma, Yunduo Liu, Qiong Wu, et al.
American Journal of Translational Research|April 15, 2022
Antibody-conjugated silica-coated gold nanoparticles in targeted therapy of cervical cancerHui Yu, Ruxin Zheng, Fei Lei, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cellular Oncology (Dordrecht, Netherlands)|January 20, 2021
Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κBWanyue Wang, Xin Li, Ye Xu, et al.
Journal of Surgical Oncology|August 5, 2011
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancerMingzhu Yin, Haiyu Zhang, Huiyan Li, et al.
Disease Markers|December 8, 2022
<i>ATAD2</i> Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune InfiltrationCan Wang, Yue Yin, Zhenxing Sun, et al.
Molecular Medicine (Cambridge, Mass.)|June 6, 2022
UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosisMengjun Zhang, Yuan Liu, Yue Yin, et al.
Frontiers in Genetics|June 6, 2022
A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian CancerMengjun Zhang, Yunduo Liu, Yuan Liu, et al.
Frontiers in Genetics|September 12, 2022
Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancerMengjun Zhang, Yunduo Liu, Yuan Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic studyYu Zhang, Le Wang, Yunduo Liu, et al.
Discover Oncology|June 25, 2024
miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transitionYing Ma, Yiru Wang, Can Wang, et al.
ACS Nano|April 2, 2019
Quercetin-Modified Metal-Organic Frameworks for Dual Sensitization of Radiotherapy in Tumor Tissues by Inhibiting the Carbonic Anhydrase IXTengchuang Ma, Yunduo Liu, Qiong Wu, et al.
American Journal of Translational Research|April 15, 2022
Antibody-conjugated silica-coated gold nanoparticles in targeted therapy of cervical cancerHui Yu, Ruxin Zheng, Fei Lei, et al.
Pageof 6